Parametric Portfolio Associates’s scPharmaceuticals SCPH Stock Holding History

Parametric Portfolio Associates’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,268	Closed	-$60K	–	3994
2019 Q3	$60K	Sell	10,268 -1,276	-11%	-$7.2K	﹤0.01%	3891
2019 Q2	$37K	Sell	11,544 -6,781	-37%	-$22.2K	﹤0.01%	3929
2019 Q1	$55K	Sell	18,325 -21,449	-54%	-$73.7K	﹤0.01%	3884
2018 Q4	$150K	Buy	39,774 +6,421	+19%	+$30.2K	﹤0.01%	3721
2018 Q3	$196K	Buy	+33,353	New	+$170K	﹤0.01%	3768

Other funds holding SCPH

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return